-
Mark Cuban drug firm adds cancer biosimilar
19 Dec 2025 18:16 GMT
… Becker’s. Cost Plus Drugs also offers Starjemza, a … ), which is approved for treatment of metastatic colorectal cancer; … cancer; recurrent glioblastoma; metastatic renal cell carcinoma; persistent, recurrent or metastatic … to order discounted medications.
-
Ambros' $125m for pain disorder drug, and other financings
19 Dec 2025 01:23 GMT
… rights to neridronate, a bisphosphonate drug marketed in Italy by Abiogen … clinical trials of its lead drugs for inherited blood disorder hereditary … lead programme, LNK001 for the treatment of renal cell carcinoma, is being prepared for …
-
RCC offering free dental X-Rays to community during winter term
18 Dec 2025 22:43 GMT
… community members.
At the RCC clinic, a full-mouth … preventive services and treatments, including sealants, fluoride treatments, debridement and … said Carmen Mons, director of RCC Dental Programs. “We’re … an appointment , call the RCC Dental Hygiene Clinic at …
-
AI Model Predicts Survival, Prioritizes Therapy in RCC
17 Dec 2025 01:32 GMT
… treatment, particularly for patients grappling with clear cell renal cell carcinoma … learning, clear cell renal cell carcinoma, LAC-TME classifier … renal cell carcinoma survivalgenomic data analysis in kidney cancerinnovative approaches in cancer treatmentLAC …
-
<![CDATA[Impact of 89Zr-girentuximab PET/CT versus conventional imaging on clinical decision making in patients with indeterminate renal masses (ZIRCON-X)]]>
19 Dec 2025 22:12 GMT
… masses suspicious for clear cell renal cell carcinoma. Results showed that nearly half … clarity and guide more appropriate treatment decisions.
-
Exploring the Therapeutic Potential of Ferroptosis in Gastric Cancer
19 Dec 2025 14:01 GMT
… the direction for the treatment of GC.
Clinical Drugs That Target Ferroptosis … and Drug Administration (FDA) for treating thyroid cancer, hepatocellular carcinoma, and renal cell carcinoma … oxidative stress. Free Radic Biol Med. 2015;89:1154–1164. doi …
-
Immune-Related Adverse Events of Checkpoint Inhibitors and Human Leukocyte Antigen System: A Review
19 Dec 2025 08:28 GMT
… United States Food and Drug Administration (FDA) and … inhibitors in stage IV renal cell carcinoma (RCC), melanoma and non- … response.36 Other immunosuppressive drugs are also used, … like syndrome complicating pembrolizumab treatment for metastatic melanoma. …
-
Genenta Science Provides Update on CEO Ownership
19 Dec 2025 07:30 GMT
… 1/2a metastatic Renal Cell Carcinoma study that will also include … checkpoint inhibitors. Genenta’s treatments are designed as one- … its clinical trial for metastatic RCC or any related studies, … U.S. Food and Drug Administration or any other regulatory …
-
Dialysis three days a week, a transplant still out of reach
18 Dec 2025 14:53 GMT
… said severe headaches sometimes follow treatment, and early on he “passed … center. He said it was renal cell carcinoma and that surgery returned “clear …
-
Werewolf Therapeutics Announces Pipeline and Business Updates
18 Dec 2025 13:00 GMT
… approximately 33% of tumors, including renal cell carcinoma, cutaneous squamous cell carcinoma, … molecules, respectively, for the treatment of solid tumors. Werewolf is … regulatory approval for investigational new drug applications; whether results from …